EP4200341A4 - Diagnostische verfahren und zusammensetzungen - Google Patents

Diagnostische verfahren und zusammensetzungen Download PDF

Info

Publication number
EP4200341A4
EP4200341A4 EP21859174.1A EP21859174A EP4200341A4 EP 4200341 A4 EP4200341 A4 EP 4200341A4 EP 21859174 A EP21859174 A EP 21859174A EP 4200341 A4 EP4200341 A4 EP 4200341A4
Authority
EP
European Patent Office
Prior art keywords
compositions
diagnostic methods
diagnostic
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP21859174.1A
Other languages
English (en)
French (fr)
Other versions
EP4200341A1 (de
Inventor
Victor Emilio MUÑOZ VAN DEN EYNDE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
University of California Berkeley
University of California San Diego UCSD
Original Assignee
University of California
University of California Berkeley
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California, University of California Berkeley, University of California San Diego UCSD filed Critical University of California
Publication of EP4200341A1 publication Critical patent/EP4200341A1/de
Publication of EP4200341A4 publication Critical patent/EP4200341A4/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4728—Calcium binding proteins, e.g. calmodulin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/082—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0008—Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/485—Exopeptidases (3.4.11-3.4.19)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/07—Bacillus
    • C12R2001/125—Bacillus subtilis ; Hay bacillus; Grass bacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y102/00—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
    • C12Y102/04—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with a disulfide as acceptor (1.2.4)
    • C12Y102/04002—Oxoglutarate dehydrogenase (succinyl-transferring) (1.2.4.2), i.e. alpha-ketoglutarat dehydrogenase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/13—Protein-histidine kinases (2.7.13)
    • C12Y207/13003—Histidine kinase (2.7.13.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/17—Metallocarboxypeptidases (3.4.17)
    • C12Y304/17023—Angiotensin-converting enzyme 2 (3.4.17.23)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Toxicology (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
EP21859174.1A 2020-08-19 2021-08-19 Diagnostische verfahren und zusammensetzungen Pending EP4200341A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202016997891A 2020-08-19 2020-08-19
US202063120704P 2020-12-02 2020-12-02
PCT/US2021/046795 WO2022040484A1 (en) 2020-08-19 2021-08-19 Diagnostic methods and compositions

Publications (2)

Publication Number Publication Date
EP4200341A1 EP4200341A1 (de) 2023-06-28
EP4200341A4 true EP4200341A4 (de) 2024-12-04

Family

ID=80323319

Family Applications (1)

Application Number Title Priority Date Filing Date
EP21859174.1A Pending EP4200341A4 (de) 2020-08-19 2021-08-19 Diagnostische verfahren und zusammensetzungen

Country Status (2)

Country Link
EP (1) EP4200341A4 (de)
WO (1) WO2022040484A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024124111A1 (en) * 2022-12-08 2024-06-13 The Regents Of The University Of California Multimeric protein complexes for neutralization of viral pathogens in diagnostic, prophylactic, and therapeutic applications
IT202200025416A1 (it) * 2022-12-13 2024-06-13 Univ Pisa Biosensore per la rilevazione di particelle virali

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197928B1 (en) * 1997-03-14 2001-03-06 The Regents Of The University Of California Fluorescent protein sensors for detection of analytes
US6221612B1 (en) * 1997-08-01 2001-04-24 Aurora Biosciences Corporation Photon reducing agents for use in fluorescence assays
WO2002082078A2 (en) * 2001-04-09 2002-10-17 Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V. Activated enzyme-linked detection systems for detecting and quantifying nucleid acids, antigens antibodies and other analytes
JP2008173018A (ja) * 2007-01-16 2008-07-31 Canon Inc 細胞培養方法及び細胞培養用基板
EP2515110B1 (de) * 2009-11-19 2015-03-25 Ushio Denki Kabushiki Kaisha Fluorimmunassay-Verfahren

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
BADASYAN A ET AL: "Probing Possible Downhill Folding: Native Contact Topology Likely Places a Significant Constraint on the Folding Cooperativity of Proteins with ~40 Residues", JOURNAL OF MOLECULAR BIOLOGY, ACADEMIC PRESS, UNITED KINGDOM, vol. 384, no. 2, 12 December 2008 (2008-12-12), pages 512 - 530, XP025609978, ISSN: 0022-2836, [retrieved on 20080917], DOI: 10.1016/J.JMB.2008.09.023 *
BOYKEN SCOTT E. ET AL: "De novo design of tunable, pH-driven conformational changes", SCIENCE, vol. 364, no. 6441, 17 May 2019 (2019-05-17), US, pages 658 - 664, XP093185999, ISSN: 0036-8075, DOI: 10.1126/science.aav7897 *
CERMINARA MICHELE ET AL: "Downhill Protein Folding Modules as Scaffolds for Broad-Range Ultrafast Biosensors", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 134, no. 19, 7 May 2012 (2012-05-07), pages 8010 - 8013, XP093186001, ISSN: 0002-7863, DOI: 10.1021/ja301092z *
G. ZHANG: "The first-in-class peptide binder to the SARS-CoV-2 spike protein", BIORXIV, 17 June 2020 (2020-06-17), pages 1 - 15, XP093162856, Retrieved from the Internet <URL:https://web.archive.org/web/20200328201339if_/https://www.biorxiv.org/content/10.1101/2020.03.19.999318v1.full.pdf> DOI: 10.1101/2020.03.19.999318 *
MUÑOZ VICTOR ET AL: "When fast is better: protein folding fundamentals and mechanisms from ultrafast approaches", BIOCHEMICAL JOURNAL, vol. 473, no. 17, 1 September 2016 (2016-09-01), GB, pages 2545 - 2559, XP093186242, ISSN: 0264-6021, Retrieved from the Internet <URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003694/pdf/bj4732545.pdf> DOI: 10.1042/BCJ20160107 *
NAGPAL SUHANI ET AL: "Downhill (Un)Folding Coupled to Binding as a Mechanism for Engineering Broadband Protein Conformational Transducers", ACS SYNTHETIC BIOLOGY, vol. 9, no. 9, 21 August 2020 (2020-08-21), Washington DC ,USA, pages 2427 - 2439, XP093185988, ISSN: 2161-5063, DOI: 10.1021/acssynbio.0c00190 *
See also references of WO2022040484A1 *
VALLEE-BELISLE A ET AL: "Structure-switching biosensors: inspired by Nature", CURRENT OPINION IN STRUCTURAL BIOLOGY, ELSEVIER LTD, GB, vol. 20, no. 4, 1 August 2010 (2010-08-01), pages 518 - 526, XP027234415, ISSN: 0959-440X, [retrieved on 20100602] *

Also Published As

Publication number Publication date
WO2022040484A1 (en) 2022-02-24
EP4200341A1 (de) 2023-06-28

Similar Documents

Publication Publication Date Title
MA54875A (fr) Compositions oligonucléotidiques et procédés associés
EP3823673A4 (de) Anti-cd112r-zusammensetzungen und verfahren
EP4027922A4 (de) Patientenspezifisches chirurgisches verfahren und instrumentarium
EP4196488C0 (de) Spaltbare linkerzusammensetzungen und verfahren
EP4399309A4 (de) Serpinamodulierende zusammensetzungen und verfahren
EP3565397A4 (de) Mikrobielle zusammensetzungen und verfahren
EP3414321A4 (de) Vcn-förderer-zusammensetzungen und verfahren zur verwendung davon
EP3565396A4 (de) Mikrobielle zusammensetzungen und verfahren
EP3877381A4 (de) Benzamide von pyrazolyl-amino-pyrimidinyl-derivaten, zusammensetzungen und verfahren dafür
EP4399306A4 (de) Pah-modulierende zusammensetzungen und verfahren
EP3803403A4 (de) Zusammensetzungen und verfahren zur bildgebung
EP3833340A4 (de) Zusammensetzungen und verfahren zur behandlung von presbyopie
MA53939A (fr) Compositions hémostatiques et leurs procédés de fabrication
MA55087A (fr) Compositions et procédés de traitement de laminopathies
EP4017924A4 (de) Oberflächenbehandlungszusammensetzungen und -verfahren
PL4208046T3 (pl) Kompozycje i sposoby
IL309079A (en) Methods and compositions
EP4146151A4 (de) Furan-tensidzusammensetzungen und verfahren
EP3817755A4 (de) Topische muskelrelaxationszusammensetzungen und verfahren
EP4463173A4 (de) Postbiotische zusammensetzungen und verfahren
EP3966328A4 (de) Anti-c9orf72-oligonukleotide und zugehörige verfahren
EP4058035A4 (de) Zusammensetzungen und verfahren für die immuntherapie
EP4200341A4 (de) Diagnostische verfahren und zusammensetzungen
EP4314050A4 (de) Bispezifische moleküle sowie zugehörige zusammensetzungen und verfahren
EP3607320A4 (de) Zusammensetzungen und verfahren zur diagnose von bauchspeicheldrüsenkrebs

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20230208

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: C12N 15/62 20060101ALI20240808BHEP

Ipc: C07K 14/00 20060101ALI20240808BHEP

Ipc: G01N 33/68 20060101ALI20240808BHEP

Ipc: G01N 33/542 20060101ALI20240808BHEP

Ipc: C07K 19/00 20060101AFI20240808BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20241105

RIC1 Information provided on ipc code assigned before grant

Ipc: C12N 15/62 20060101ALI20241029BHEP

Ipc: C07K 14/00 20060101ALI20241029BHEP

Ipc: G01N 33/68 20060101ALI20241029BHEP

Ipc: G01N 33/542 20060101ALI20241029BHEP

Ipc: C07K 19/00 20060101AFI20241029BHEP